Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis
Authors
Keywords
Gene amplification, Comparative genomics, Adenocarcinomas, Polymerase chain reaction, Carcinogenesis, Apoptosis, Carcinomas, Genomic medicine
Journal
PLoS One
Volume 8, Issue 3, Pages e57724
Publisher
Public Library of Science (PLoS)
Online
2013-03-05
DOI
10.1371/journal.pone.0057724
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas
- (2012) Sohei Yamamoto et al. HISTOPATHOLOGY
- Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer
- (2012) Shinya Akatsuka et al. PLoS One
- XCR1 Expression and Biased VHGene Usage Are Distinct Features of Diffuse Large B-Cell Lymphoma Initially Manifesting in the Bone Marrow
- (2011) Yoriko Yamashita et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
- (2011) Mohammed Tanjimur Rahman et al. CANCER
- The Akt kinases: Isoform specificity in metabolism and cancer
- (2011) Eva Gonzalez et al. CELL CYCLE
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient
- (2011) Sohei Yamamoto et al. MODERN PATHOLOGY
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma
- (2010) K. T. Kuo et al. CLINICAL CANCER RESEARCH
- Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma
- (2010) Qian Hu et al. LABORATORY INVESTIGATION
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
- (2009) T. Y. Seiwert et al. CANCER RESEARCH
- Role of iron in carcinogenesis: Cancer as a ferrotoxic disease
- (2009) Shinya Toyokuni CANCER SCIENCE
- Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management
- (2009) Masaki Mandai et al. International Journal of Clinical Oncology
- IncreasedMETGene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
- (2009) Federico Cappuzzo et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
- (2008) Hiroaki Itamochi et al. CANCER SCIENCE
- Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress
- (2008) K. Yamaguchi et al. CLINICAL CANCER RESEARCH
- HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells
- (2008) T. Bachleitner-Hofmann et al. MOLECULAR CANCER THERAPEUTICS
- Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion
- (2007) E.C. KOON et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now